Combination of artificial liver support system and nucleoside analogue treatment improves long-term outcomes of patients with HBV-associated acute-on-chronic liver failure: A single-center experience

P053 Combination of artificial liver support system and nucleoside analogue treatment improves long-term outcomes of patients with HBVassociated acute-on-chronic liver failure: A single-center experience G Qin, Y Shen, J-G Shao, Y-Y Zhang, Y-M Liu, B Wang and L-J Wang Nantong University, Center for Liver Diseases, Nantong Third People’s Hospital, Nantong, China, Department of Epidemiology and Medical Statistics, Nantong University, Nantong, China